Plasmodium yoelii: Activity of azithromycin in combination with pyrimethamine or sulfadoxine against blood and sporozoite induced infections in Swiss mice

Experimental Parasitology

Volumn 107, Issue 3-4, 2004, Pages 120-124

  Neerja, J ^a   Puri, S K ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Antimalarial drug combination; Azithromycin; Malaria; Plasmodium yoelii; Pyrimethamine; Sulfadoxine

Indexed keywords

ANTIMALARIAL AGENT; AZITHROMYCIN; FANSIDAR; PYRIMETHAMINE; SULFADOXINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMALARIAL ACTIVITY; ARTICLE; BLOOD; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG ACTIVITY; DRUG EFFICACY; DRUG POTENTIATION; DRUG RESPONSE; EXPERIMENTAL INFECTION; INFECTION PREVENTION; MALARIA; MOUSE; NONHUMAN; OUTBRED STRAIN; PARASITEMIA; PLASMODIUM YOELII; PRIORITY JOURNAL; RODENT; SPOROZOITE; TREATMENT OUTCOME;

ANIMALS; ANTIMALARIALS; AZITHROMYCIN; CHLOROQUINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FEMALE; MALARIA; MALE; MICE; PARASITEMIA; PLASMODIUM YOELII; PYRIMETHAMINE; SPOROZOITES; SULFADOXINE;

PLASMODIUM FALCIPARUM; PLASMODIUM YOELII; RODENTIA;

EID: 4444239011     PISSN: 00144894     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exppara.2004.05.005     Document Type: Article

References (10)

1. Andersen S.L., Ager A., McGreevy P., Schuster B.G., Wesohe R., Kushner R., Ohrt C., Ellis W., Rossan R., Berman J. Activity of azithromycin as a blood schizontocide against rodent and human Plasmodia in vivo. Am. J. Trop. Med. Hyg. 52:1995;159-161
2. Blais J., Garneau V., Chamberland S. Inhibition of Toxoplasma gondii protein synthesis by azithromycin. Antimicrob. Agents Chemother. 37:1993;1701-1703
3. Ogutu R.B., Smoak B.L., Nduari R.W., Mbori-Ngacha D.A., Mwathe F., Shanks G.D. The efficacy of pyrimethamine-sulfadoxine (Fansidar) resistance of Plasmodium falciparum malaria in Kenyan children. Trans. R. Soc. Trop. Med. Hyg. 94:2000;83-84
4. Ohrt C., Willingmyre G.D., Lee P., Knirsch C., Milhous W. Assessment of azithromycin in combination with other antimalarial drugs against P. falciparum in vitro. Antimicrob. Agents Chemother. 46:2002;2518-2524
5. Puri S.K., Singh N. Azithromycin: antimalarial profile against blood and sporozoite induced infections in mice and monkeys. Exp. Parasitol. 94:2000;8-14
6. Retsema J., Girard A., Schelkly W., Manousor M., Anderson M., Bright G., Boronoy R., Brounan L., Mason R. Spectrum and mode of action of azithromycin (CP62993), a new 15 membered ring macrolide with improved potency against grain negative organisms. Antimicrob. Agents Chemother. 31:1987;1939-1947
7. Ronn A.M., Msangeni H.A., Mhina J., Wernsdorfer W.H., Bygbjerg I.C. High level of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine in children in Tanzania. Trans. R. Soc. Trop. Med. Hyg. 90:1996;179-181
8. Sibley C.H., Hyde J.E., Sims P.F.G., Plowe C.V., Kublin J.G., Mberu E.K., Cowman A.F., Winstanley P.A., Watkins W.M., Nzila A.M. Pyrimethamine sulfadoxine resistance in Plasmodium falciparum: what next? Trends Parasitol. 17:2001;582-588
9. Taylor W.R.J., Richie T.L., Fryauff D.J., Picarima H., Ohrt C., Tang D., Braitman D., Murphy D.S., Widjaja H., Tjitra E., Ganjar A., Jones T.R., Basri H., Berman J. Malaria prophylaxis using azithromycin: a double-blind placebo controlled trial in Irian Java, Indonesia. Clin. Infect. Dis. 24:1999;76-77
10. WHO, 2001. Antimalarial drug combination therapy. Report of a WHO Technical Consultation. World Health Organization, Geneva, pp. 1-36